![](https://cahal.nl/wp-content/uploads/2022/06/Maik-Grundeken-300x275-1.jpg)
Publicaties
2024-07-01
Paclitaxel-coated balloons for vulnerable lipid-rich plaques.
van Veelen A, Küçük IT, Garcia-Garcia HM, Fuentes FH, Kahsay Y, Delewi R, Beijk MAM, den Hartog AW, Grundeken MJ, Vis MM, Henriques JPS, Claessen BEPM.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Edition: 1774-024X | Pages: e826-e830
Lees artikel
2024-05-01
Microplastics and Nanoplastics in Atheromas.
Kalkman DN, Renkens MPL, Grundeken MJ.
The New England journal of medicine
Edition: 0028-4793 | Pages: 1726
Lees artikel
2024-03-04
Correction: van Veelen et al. First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study. J. Clin. Med. 2023, 12, 5807.
van Veelen A, Küçük IT, Fuentes FH, Kahsay Y, Garcia-Garcia HM, Delewi R, Beijk MAM, den Hartog AW, Grundeken MJ, Vis MM, Henriques JPS, Claessen BEPM.
Journal of clinical medicine
Edition: 2077-0383 | Pages: 1479
Lees artikel
2023-09-06
First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study.
van Veelen A, Küçük IT, Fuentes FH, Kahsay Y, Garcia-Garcia HM, Delewi R, Beijk MAM, den Hartog AW, Grundeken MJ, Vis MM, Henriques JPS, Claessen BEPM.
Journal of clinical medicine
Edition: 2077-0383 | Pages: 5807
Lees artikel
2023-06-09
Impact of the COVID-19 Outbreak on the Treatment of Myocardial Infarction Patients.
Grundeken MJ, Claessen BEPM.
Current treatment options in cardiovascular medicine
Edition: 1092-8464 | Pages: 1-11
Lees artikel